Volume : 7, Issue : 5, May - 2018

Postplacental IUCD insertion -An observational study at a tertiary care centre

Archana Goyal

Abstract :

<p class="MsoNormal" style="margin-top:15.4pt;margin-right:0in;margin-bottom:&#10;7.7pt;margin-left:0in;line-height:15.0pt;mso-outline-level:3;background:white"><b><span style="font-size:12.0pt;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;;mso-fareast-font-family:&#10;&quot;Times New Roman&quot;;color:#724128">Background &amp; objectives:<o:p></o:p></span></b></p> <p class="MsoNormal" style="margin-top:8.3pt;margin-right:0in;margin-bottom:8.3pt;&#10;margin-left:0in;line-height:normal;background:white"><span style="font-size:&#10;12.0pt;font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;mso-fareast-font-family:&quot;Times New Roman&quot;;&#10;color:black">In view of high rate of unintended pregnancy in our country, particularly in post-partum women, there is a need for reliable, effective, long-term contraception such as intrauterine device (IUD) in post-partum women. The present study was planned to evaluate the safety and efficacy of immediate post-partum IUD insertion.<o:p></o:p></span></p> <p class="MsoNormal" style="margin-top:15.4pt;margin-right:0in;margin-bottom:&#10;7.7pt;margin-left:0in;line-height:15.0pt;mso-outline-level:3;background:white"><b><span style="font-size:12.0pt;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;;mso-fareast-font-family:&#10;&quot;Times New Roman&quot;;color:#724128">Methods:<o:p></o:p></span></b></p> <p class="MsoNormal" style="margin-top:8.3pt;margin-right:0in;margin-bottom:8.3pt;&#10;margin-left:0in;line-height:normal;background:white"><span style="font-size:&#10;12.0pt;font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;mso-fareast-font-family:&quot;Times New Roman&quot;;&#10;color:black">The women recruited had CuT 380A insertion immediately after delivery of placenta in vaginal <span style="mso-spacerun:yes">&nbsp;</span>delivery. Women having post-partum haemorrhage (PPH), anaemia, pre-labour rupture of memanes &gt;18 h, obstructed labour and distorted uterine cavity by fioid or by congenital malformation were excluded from the study. The women were followed up at 6 wk <span style="mso-spacerun:yes">&nbsp;</span>after delivery.<o:p></o:p></span></p> <p class="MsoNormal" style="margin-top:15.4pt;margin-right:0in;margin-bottom:&#10;7.7pt;margin-left:0in;line-height:15.0pt;mso-outline-level:3;background:white"><b><span style="font-size:12.0pt;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;;mso-fareast-font-family:&#10;&quot;Times New Roman&quot;;color:#724128">Results:<o:p></o:p></span></b></p> <p class="MsoNormal" style="line-height:normal"><span style="font-size:12.0pt;&#10;font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;mso-fareast-font-family:&quot;Times New Roman&quot;;&#10;color:black">A total of 250 women were included in the study.</span><span style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;,&quot;serif&quot;">The present study shows that<span style="mso-spacerun:yes">&nbsp; </span>expulsion rate <span style="mso-spacerun:yes">&nbsp;</span>in postplacental insertion group i.e. 13.2% .Removal rate of PPIUCD(Post partum Intrauterine Contraceptive device) in postplacental insertion i.e.43 (17.2%) cases.Most common cause of removal of PPIUCD in our study was pelvic pain and menstrual disturbances.<o:p></o:p></span></p> <p class="MsoNormal" style="line-height:normal"><b><span style="font-size:12.0pt;&#10;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;;mso-fareast-font-family:&quot;Times New Roman&quot;;&#10;color:#724128">Interpretation &amp; conclusions:</span></b><span style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;,&quot;serif&quot;">Thus from our study it is concluded that PPIUCD<span style="mso-spacerun:yes">&nbsp; </span>is safe, convenient, cost effective, reversible and long term birth spacing method. It should be part of a maternal/newborn/reproductive health package.<o:p></o:p></span></p>